Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2022
Homologous recombination-deficient mutation cluster in tumor suppressor <i>RAD51C</i> identified by comprehensive analysis of cancer variantsRohit Prakash, Yashpal Rawal, Meghan R Sullivan, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 9, 2008
NCCN Task Force Report: breast cancer in the older womanRobert W Carlson, Susan Moench, Arti Hurria, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast CancerSteven J Isakoff, Erica L Mayer, Lei He, et al.Clinical Breast Cancer|October 12, 2015
A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast CancerNeil M Iyengar, Monica N Fornier, Steven M Sugarman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019Costanza Paoletti, Yufeng Li, Maria C Muñiz, et al.Clinical Breast Cancer|May 8, 2025
Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer SymposiumKomal Jhaveri, Carey K Anders, Aditya Bardia, et al.Journal of the National Cancer Institute|October 11, 2025
Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030)Guilherme Nader-Marta, Xiangying Chu, Satabhisa Mukhopadhyay, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2013
Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast CancerAyca Gucalp, Sara Tolaney, Steven J Isakoff, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast CancerAndres Forero-Torres, Katherine E Varley, Vandana G Abramson, et al.European Heart Journal|February 22, 2023
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trialJessica M Scott, Jasme Lee, James E Herndon, et al.Pageof 7